When the Strategic Patient Registry Program Makes Sense.
Track & Assess New Therapies
The effectiveness of new anti-infectives and injectible drugs can be assessed with the ClinicalPURSUIT Registry. It can allow the collection of up-to-date information in a standardized format and provide outcome indicators when antibiotics and treatments are released for general use. You don’t experience the time delay found in reporting about new therapies through publications.
A Companion to Clinical Trials
The Registry can also avoid the possible bias involved in studying the patients selected for Phase II and III trials as it would present data on all patients treated with the selected therapies. This creates a means of tracking the therapies that are really being used and what they are being used for in the country. It can also allow a continual follow up for adverse effects of new therapies that would be timely and give an ongoing mechanism to compare adverse events of new therapies with those of old ones.
Create a Forum for Communication
The information gathered by the ClinialPURSUITRegistry can be used for a variety of other purposes as well. The indicators of clinical and bacterial outcomes can be used to evaluate different treatment regimens, and gain insight into the most effective drug therapy dosing and duration of therapy. This information can be presented in an interactive format on the Internet and through posters, publications and presentations.
Strengthen Decision Making
It can allow an added perspective in therapy decision-making with continual updating and a critical mass of data that will provide statistically significant values for analysis with many disease states. The Strategic Patient Registry Program and the ClinicalPURSUIT platform can provide a system that incorporates a true learning process with a real-time, live database.
Data collected through ClinicalPURSUIT can also be used to monitor any resistance to therapies by collecting critical data findings at the start and end of therapy. This can provide reflections of the levels of resistance in serious situations and infections in the community and identify organisms that develop resistance during therapy.